Wednesday, September 9, 2009

SEC Charges Biotech Company With Fraudulently Hyping Stem Cell Breakthrough

The SEC has filed charges CellCyte Genetics Corporation its former CEO, and its former Chief Scientific Officer for falsely telling investors that the company's cutting-edge stem cell technology had been proven successful and was headed for human trials. More>>>

Post a Comment